Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Allakos revenue
Allakos's revenue is $15.6 million.
What is Allakos's revenue?
- Allakos has 125 employees, and the revenue per employee ratio is $124,400.
- Allakos peak revenue was $15.6M in 2024.
On this page
Zippi applies for you, and finds you a job.
Allakos financial information
| CEO | Robert Alexander |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 125 |
| Date Founded | 2012 |
| Headquarters | Redwood City, California |
| Revenue | $15.6M |
| Net Income | -$319,952,000 |
| Tax Rate | 0.0% |
| Total Assets | $386,420,000 |
| Ticker | ALLK |
Allakos jobs you might like
Allakos financing
Allakos received early financing of $27.9M on 2012-12-07.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $27.9M | 12/2012 |
| Series A | $24.5M | 08/2014 |
| Series A | $10M | 09/2014 |
| Series B | $100M | 12/2017 |
Allakos investors
| Investors | Security type |
|---|---|
| Novo Ventures | Series A |
| Alta Partners | Series A |
| Roche Venture Fund | Series A |
| RiverVest Venture Management LLC | Series A |
| Novo Ventures | Series A |
| Alta Partners | Series A |
| Roche Venture Fund | Series A |
| RiverVest Venture Management LLC | Series A |
| PARTNER FUND MANAGEMENT | Series B |
| LifeSci Advisors | Series B |
| Redmile Group | Series B |
| New Enterprise Associates | Series B |
| Roche Venture Fund | Series B |
| Alta Partners | Series B |
| 3x5 Partners | Series B |
| Rock Springs Capital | Series B |
| Samsara BioCapital | Series B |
| RiverVest Venture Management LLC | Series B |
Allakos competitors
Allakos's top competitor, Axsome Therapeutics, earned an annual revenue of $385.7M.
Allakos's smallest competitor is Checkpoint Therapeutics with revenue of $41.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Outlook Therapeutics | - | $8.1M | 10 | - |
| Axsome Therapeutics | - | $385.7M | 29 | - |
| Silverback Therapeutics | - | $1.3M | 5 | - |
| Xencor | - | $110.5M | 156 | - |
| Apexigen | - | $4.9M | 39 | - |
| Checkpoint Therapeutics | - | $41,000 | 7 | - |
| Cerecor | - | $6.7M | 32 | - |
| Seelos Therapeutics | - | $375,000 | 10 | - |
| Ancora Pharmaceuticals | - | $670,000 | 1 | - |
| Akari Therapeutics | - | $1.6M | 8 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Allakos highest paying jobs
Zippia gives an in-depth look into the details of Allakos, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Allakos. The employee data is based on information from people who have self-reported their past or current employments at Allakos. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Allakos. The data presented on this page does not represent the view of Allakos and its employees or that of Zippia.
Allakos may also be known as or be related to ALLAKOS INC., Allakos, Allakos Inc and Allakos Inc.